CGT Catapult Morning Tips webinar series exploring the latest challenges and solutions in ATMP development and manufacturing.
In this block, topics covered during the webinars include:
- Realising gene therapy's potential: viral or non-viral delivery
- On the horizon: ex vivo and in vivo gene editing methods
- Expanding the application of novel gene-editing technologies
This 20-minute talk will be followed by a 10-minute Q&A session with the speakers.
Joe Healey - CEO and Co-Founder, NanoSyrinx
Abhishek Srivastava - Senior Industrialisation Scientist – Gene Editing, CGT Catapult